Aclaris Therapeutics Prices $50 Million Stock and Warrant Offering
Aclaris Therapeutics priced a $50 million offering of common stock and pre-funded warrants.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Aclaris Therapeutics Prices $50 Million Stock and Pre-Funded Warrant Offering
Aclaris Therapeutics announced pricing of a $50.0 million offering of common stock and pre-funded warrants.